CYP4B1 and urinary bladder carcinoma: Genetic polymorphism analysis revealed that two allelic combinations, CYP4B1/*1/*2 and CYP4B1/*2/*2, are associated with an increased risk of bladder cancer in the Japanese population [109]; however, as mentioned above, CYP4B1*2 results in an inactive enzyme [101].